We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
Thanks to the Nagel Foundation and their generous support of NHF Idaho.
UniQure recently announced plans to “expeditiously advance” its investigational hemophilia B gene therapy AMT-061 into a pivotal study in 2018. The announcement followed meetings the company had with both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency.
Researchers have made an important discovery that could change the way doctors understand and treat inhibitor development in hemophilia A
Actions from the President adds uncertainty to the health insurnace market.
The National Hemophilia Foundation is pleased to announce that Michael Kuklish of Lillian, Alabama, is the recipient of the 2017 Kevin Child Scholarship.
Subscribe to Our Newsletter
Fill in the fields below to receive our email newsletter.